Loading...
Rationally Designed Dendritic Silica Nanoparticles for Oral Delivery of Exenatide
Type 2 diabetes makes up approximately 85% of all diabetic cases and it is linked to approximately one-third of all hospitalisations. Newer therapies with long-acting biologics such as glucagon-like peptide-1 (GLP-1) analogues have been promising in managing the disease, but they cannot reverse the...
Na minha lista:
| Udgivet i: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6723263/ https://ncbi.nlm.nih.gov/pubmed/31430872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11080418 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|